DA5-CH and Semaglutide Protect against Neurodegeneration and Reduce α-Synuclein Levels in the 6-OHDA Parkinson's Disease Rat Model

Insulin desensitization has been observed in the brains of patients with Parkinson's disease (PD), which is a progressive neurodegenerative disorder for which there is no cure. Semaglutide is a novel long-actingglucagon-likepeptide-1 (GLP-1) receptor agonist that is on the market as a treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lingyu, Li, Chun, Zhang, Zijuan, Zhang, Zhenqiang, Jin, Qian-Qian, Li, Lin, Hölscher, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678466/
https://www.ncbi.nlm.nih.gov/pubmed/36419409
http://dx.doi.org/10.1155/2022/1428817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678466/
https://www.ncbi.nlm.nih.gov/pubmed/36419409
http://dx.doi.org/10.1155/2022/1428817

Ejemplares similares